Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress.
about
Plant Polyphenols as Chemopreventive Agents for Lung CancerAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersClinical Safety of a High Dose of Phycocyanin-Enriched Aqueous Extract from Arthrospira (Spirulina) platensis: Results from a Randomized, Double-Blind, Placebo-Controlled Study with a Focus on Anticoagulant Activity and Platelet ActivationCancer chemoprevention: current state of the artEffect of plant extracts on H2O2-induced inflammatory gene expression in macrophages.Antioxidant and antiapoptotic effects of pine needle powder ingestion and endurance training in high cholesterol-fed rats.Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouseIdentification and characterization of [6]-shogaol from ginger as inhibitor of vascular smooth muscle cell proliferation.Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived ModelsWithania somnifera: From prevention to treatment of cancerGreen tea catechins: a fresh flavor to anticancer therapy.Pharmacologic overview of Withania somnifera, the Indian Ginseng.Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes.Anti-Inflammatory Diet in Clinical Practice: A Review.Hypoxia mediated pulmonary edema: potential influence of oxidative stress, sympathetic activation and cerebral blood flow.Protandim Protects Oligodendrocytes against an Oxidative Insult.The anti-obesity effects of EGCG in relation to oxidative stress and air-pollution in China.Activation of the molecular and functional effects of Nrf2 against chronic iron oxide nanorod overload-induced cardiotoxicity.Myofibrillogenesis regulator-1 attenuated hypoxia/reoxygenation-induced apoptosis by inhibiting the PERK/Nrf2 pathway in neonatal rat cardiomyocytes.Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.Characterization of the Antioxidant Effects of γ-Oryzanol: Involvement of the Nrf2 Pathway.Influence of Nrf2 activators on subcellular skeletal muscle protein and DNA synthesis rates after 6 weeks of milk protein feeding in older adults.Effects of naringenin and its phase II metabolites onin vitrohuman macrophage gene expression
P2860
Q26739975-B35BB3C6-0157-49C8-901C-E71FDB66BE6AQ28389419-849E6BE2-68A0-40E0-8E70-7B6C2E3ED337Q28395641-0E17E4FA-6606-4ABB-8CB9-878E445A357CQ30377095-078EB5C2-E2B6-4F2D-A38D-94A84D1312DEQ33783754-B7D3A6A8-F199-4DF4-86BD-958046967A19Q33930022-C975398B-F2CD-48D4-98F9-1F039F88A3B7Q34563242-16C181F4-0767-4CC6-96F7-429AB9F87D8BQ35049360-EEF6C1BA-4A2D-4F54-AB21-F15A8958C002Q36069458-F81A9390-D1F8-438B-8158-D80C3ACA9928Q36260040-11C06AA8-F353-4BD5-9DB9-C17468703B79Q36984280-9B49B253-E041-472B-BB09-6A34A92A4E01Q38147993-962EA9F6-B551-4D56-891C-EB2972A39328Q38573788-7277564D-2881-435A-BFC8-8A8CA7CBB569Q38771849-C5C1DEEA-E596-4469-8236-4F2D2135E8DAQ39204855-C239EA34-8648-44A5-92FC-A1A361C199EBQ41063916-A40454D7-C12C-4B69-B08C-B7CA1BACA3E1Q41202620-8C70A433-7E71-4BD0-A44C-31D11812FDFBQ46096053-40A1C26A-BB46-4F34-8D25-99BC6589B155Q46254751-9C7F7958-AC13-42EA-A8B0-9F8FB1848BD5Q51672326-923DA02E-1262-4B79-AFCE-B9C7A843D7BBQ53681663-114DD429-E46C-46AA-9C85-6CC18DFA9118Q54446556-443DAC01-F386-4D18-AE98-028AA4410858Q54879141-0D4347AF-B388-4F24-87BA-4147CB33D897Q58804098-9346F733-C6EF-48CF-8A44-4B2AA04687F6
P2860
Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@ast
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@en
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@nl
type
label
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@ast
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@en
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@nl
prefLabel
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@ast
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@en
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@nl
P2093
P1476
Upregulation of phase II enzym ...... ocytes against oxidant stress.
@en
P2093
Christopher J Castle
Danielle J Reuland
David C Irwin
Joe M McCord
Karyn L Hamilton
Shadi Khademi
P304
P356
10.1016/J.FREERADBIOMED.2012.11.016
P577
2012-11-30T00:00:00Z